Hochedlinger K - Search Results

1

Blanpain C, Daley GQ, Hochedlinger K, Passegué E, Rossant J, Yamanaka S. Blanpain C, et al. Among authors: hochedlinger k. Nat Rev Mol Cell Biol. 2012 Jun 8;13(7):471-6. doi: 10.1038/nrm3371. Nat Rev Mol Cell Biol. 2012. PMID: 22678486 Review.

2

Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy.

Rideout WM 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Rideout WM 3rd, et al. Among authors: hochedlinger k. Cell. 2002 Apr 5;109(1):17-27. doi: 10.1016/s0092-8674(02)00681-5. Cell. 2002. PMID: 11955443 Free article.

3

Nuclear transplantation, embryonic stem cells and the potential for cell therapy.

Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R. Hochedlinger K, et al. Hematol J. 2004;5 Suppl 3:S114-7. doi: 10.1038/sj.thj.6200435. Hematol J. 2004. PMID: 15190291 Review.

4

New advances in iPS cell research do not obviate the need for human embryonic stem cells.

Hyun I, Hochedlinger K, Jaenisch R, Yamanaka S. Hyun I, et al. Among authors: hochedlinger k. Cell Stem Cell. 2007 Oct 11;1(4):367-8. doi: 10.1016/j.stem.2007.09.006. Cell Stem Cell. 2007. PMID: 18371375 Free article. No abstract available.

5

Disease-specific induced pluripotent stem cells.

Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Park IH, et al. Among authors: hochedlinger k. Cell. 2008 Sep 5;134(5):877-86. doi: 10.1016/j.cell.2008.07.041. Epub 2008 Aug 7. Cell. 2008. PMID: 18691744 Free PMC article.

6

Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.

Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, Gao Y, Zhang K. Deng J, et al. Among authors: hochedlinger k. Nat Biotechnol. 2009 Apr;27(4):353-60. doi: 10.1038/nbt.1530. Epub 2009 Mar 29. Nat Biotechnol. 2009. PMID: 19330000 Free PMC article.

7

Cross-regulation of the Nanog and Cdx2 promoters.

Chen L, Yabuuchi A, Eminli S, Takeuchi A, Lu CW, Hochedlinger K, Daley GQ. Chen L, et al. Among authors: hochedlinger k. Cell Res. 2009 Sep;19(9):1052-61. doi: 10.1038/cr.2009.79. Epub 2009 Jun 30. Cell Res. 2009. PMID: 19564890

8

Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells.

Utikal J, Maherali N, Kulalert W, Hochedlinger K. Utikal J, et al. Among authors: hochedlinger k. J Cell Sci. 2009 Oct 1;122(Pt 19):3502-10. doi: 10.1242/jcs.054783. Epub 2009 Sep 1. J Cell Sci. 2009. PMID: 19723802 Free PMC article.

9

Induced pluripotent stem cells and reprogramming: seeing the science through the hype.

Izpisúa Belmonte JC, Ellis J, Hochedlinger K, Yamanaka S. Izpisúa Belmonte JC, et al. Among authors: hochedlinger k. Nat Rev Genet. 2009 Dec;10(12):878-83. doi: 10.1038/nrg2700. Epub 2009 Oct 27. Nat Rev Genet. 2009. PMID: 19859062 Review.

10

A reprogrammable mouse strain from gene-targeted embryonic stem cells.

Stadtfeld M, Maherali N, Borkent M, Hochedlinger K. Stadtfeld M, et al. Among authors: hochedlinger k. Nat Methods. 2010 Jan;7(1):53-5. doi: 10.1038/nmeth.1409. Epub 2009 Dec 13. Nat Methods. 2010. PMID: 20010832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page